As of Jan 19
| 0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Arch Therapeutics Inc have a median target of 2.42, with a high estimate of 3.00 and a low estimate of 1.85. The median estimate represents a +432.97% increase from the last price of 0.46.
The current consensus among 2 polled investment analysts is to Buy stock in Arch Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.